Teon Therapeutics

Developer of small molecules of drugs for cancer immunotherapy

placeRedwood City, California, United States calendar_todayFounded 2018 groups9 employees language teontherapeutics.com

Innovation

15 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 602 times.

YearFilings
20191
20202
20214
20227
202310
20246
20251
20263

Investor mix

5 investors on record; lead investors include Oceanpine Capital.

Investor typeCountShare
Venture capital480%
Other / undisclosed120%
Coming soon